Author： Baldessarini R.J.
Publisher： Elsevier
ISSN： 0165-6147
Source： Trends in Pharmacological Sciences, Vol.22, Iss.1, 2001-01, pp. : 49-50
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Progress in Colorectal Cancer Chemotherapy: How Far Have We Come, How Far to Go?
By Royce M.E.
Drugs & Aging, Vol. 17, Iss. 3, 2000-09 ,pp. :
Access to resources
Recommend
Pharmacogenetics in clinical practice: how far have we come and where are we going?
Pharmacogenomics, Vol. 14, Iss. 7, 2013-05 ,pp. :
Disease-Modifying Therapies in Alzheimer's Disease: How Far Have We Come?
By Hüll Michael Berger Mathias
Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. :
Drug metabolism and atypical antipsychotics
By Prior T.I. Chue P.S. Tibbo P. Baker G.B.
European Neuropsychopharmacology, Vol. 9, Iss. 4, 1999-06 ,pp. :